98 results
8-K
EX-99.1
NVRO
Nevro Corp
9 May 19
Nevro Reports First Quarter 2019 Financial Results
4:18pm
financial performance and long-term shareholder value,” said D. Keith Grossman, President and CEO. “The Company enjoys differentiated products based … liabilities
Long-term debt
Long-term operating lease liabilities
Other long-term liabilities
Total liabilities
Stockholders’ equity
Common stock
8-K
EX-99.1
NVRO
Nevro Corp
19 Jul 21
Results of Operations and Financial Condition
7:10am
now begin commercial launch activities in the U.S. and believe this new indication will be an important driver of the long-term growth of our business … Nevro’s proven 10 kHz Therapy, which may enable discontinuation of long-term drug therapy and eliminate unwanted drug side effects, is a welcome
8-K
EX-99.1
NVRO
Nevro Corp
8 Aug 19
Nevro Reports Second Quarter 2019 Financial Results
4:17pm
assets
Liabilities and stockholders’ equity
Current liabilities
Accounts payable
Accrued liabilities and other
Total current liabilities
Long-term debt …
Long-term operating lease liabilities
Other long-term liabilities
Total liabilities
Stockholders’ equity
Common stock, $0.001 par value, 290,000,000
8-K
EX-99.2
NVRO
Nevro Corp
7 Jan 19
Results of Operations and Financial Condition
9:10am
38 PEER REVIEWED PUBLICATIONS 1ST AND ONLY TO SHOW EFFICACY IN BACK PAIN 4 PROSPECTIVE LONG-TERM STUDIES (24-48 MONTHS) 310 PATIENTS STUDIED TO 24 … , Lucas, Jonathan. Long-Term Improvements in Chronic Axial Low Back Pain Patients Without Previous Spinal Surgery: A Cohort Analysis of 10-kHz High
8-K
EX-99.1
NVRO
Nevro Corp
1 Aug 23
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
4:10pm
% on a constant currency basis.
"While we are encouraged by the early signs of recovery and the long-term outlook of the SCS market, the market recovery … significant long-term shareholder return:
First, we are moving quickly to ensure we have top talent at every position to increase sales productivity
8-K
EX-99.1
i2ugy 5dh1v1952j
21 Feb 19
Nevro Reports Fourth Quarter and Full Year 2018 Financial Results
4:17pm
8-K
EX-99.1
le2e8bww6zfkhu 76
1 Nov 23
Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
4:07pm
8-K
EX-99.1
qus wphuhb
21 Feb 24
Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
4:09pm
8-K
EX-99.1
h5u zjdnbw0
1 Dec 23
Nevro Announces Acquisition of Vyrsa™ Technologies
6:07am
8-K
EX-99.1
eid76
9 Jan 24
Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
8:41am
8-K
EX-99.1
0xkx1
7 May 24
Nevro Reports First-Quarter 2024 Financial Results
4:11pm
8-K
EX-99.1
lq6 ubb0rz
6 Nov 19
Nevro Reports Third Quarter 2019 Financial Results
4:16pm
8-K
EX-99.1
t2la2ic8
5 Aug 20
Nevro Announces Second Quarter 2020 Financial Results
4:19pm
8-K
EX-99.1
yu5k8
21 Feb 24
Nevro Enters Into Cooperation Agreement With Engaged Capital
4:11pm
8-K
EX-99.1
e8zdo06kda
25 Feb 20
Nevro Reports Fourth Quarter and Full Year 2019 Financial Results
4:22pm
8-K
EX-99.1
idnkook yc8g9z533ujz
5 May 20
Nevro Reports First Quarter 2020 Financial Results
4:16pm
8-K
EX-99.1
jh8kvi
5 Nov 20
Nevro Announces Third Quarter 2020 Financial Results
4:18pm
8-K
EX-99.1
uwgeui
2 Aug 18
Nevro Reports Second Quarter 2018 Financial Results
12:00am
8-K
EX-99.1
uepzs4kprhabw29 wp
5 Nov 18
Nevro Reports Third Quarter 2018 Financial Results
12:00am
8-K
EX-99.1
rlo9o6yoncjtmi 765
4 Aug 21
Nevro Reports Second Quarter 2021 Financial Results and Provides Third Quarter of 2021 Guidance
4:20pm